CWT 004
Alternative Names: CWT-004Latest Information Update: 05 Feb 2021
At a glance
- Originator Causeway Therapeutics; University of Edinburgh
- Class MicroRNAs; Skin disorder therapies
- Mechanism of Action MicroRNA modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Wounds
Most Recent Events
- 27 Jan 2021 Early research in Wounds in United Kingdom (Parenteral), prior to January 2021 (Causeway therapeutics pipeline, January 2021)